Latest Thrombolysis Stories

NORDISTEMI: first trial to study the effect of early PCI after fibrinolysis in rural areas with very long transfer delays.Results from the NORwegian study on DIstrict treatment of ST-Elevation Myocardial Infarction (NORDISTEMI) show that patients presenting with acute ST-elevation myocardial infarction (STEMI) in rural areas have a better treatment outcome with thrombolysis followed by immediate transfer for angiography than with thrombolysis and conservative, community-hospital follow-up.The...

A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography. This is the STREAM trial whose principal investigators are Profs Frans van der Werf, Paul Armstrong and Tony Gershlick.Acute occlusion of a major coronary artery due to disruption of an atheromatous plaque and the formation of occlusive thrombus has major clinical implications. At the moment of cessation of the...

Heart attack patients who undergo angioplasty within six hours of receiving clot-busting drugs, have better outcomes, Canadian medical researchers say. Dr. Warren Cantor of Southlake Regional Health Center in Newmarket, Ontario, and Dr. Shaun Goodman of St. Michael's Hospital in Toronto say their study involved a large group of Canadian cardiologists, internists, emergency department physicians and paramedics. It was supported by the Canadian Institutes of Health Research and coordinated...

WALTHAM, Mass., June 25 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over the next five years due to growing physician interest in treating deep vein thrombosis (DVT). Although the ATTRACT (Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed thrombolysis...

Transferring heart attack patients to specialized hospitals to undergo angioplasty within six hours after receiving clot-busting drugs reduces the risk of life-threatening complications including repeat heart attacks, according to a new study from St. Michael's Hospital and Southlake Regional Hospital.The findings, published today in the New England Journal of Medicine, suggest that routine early transfer of patients after clot-busting drugs are administered results in significantly better...

A committee of medical experts has extended the treatment window for a stroke from three hours to 4 1/2 hours after symptoms arise.When a person begins showing signs of a stroke "“ numbness or weakness in the face, arm or leg; trouble speaking, seeing or walking; a sudden headache "“ timing is crucial. The sooner they seek medical help, the more likely they are to recover without substantial brain damage.The initial window for treatment using clot-busting drugs in stroke patients was once...

Giving clot-busting drugs to patients who wake up with stroke symptoms appears to be as safe as giving it to those in the recommended three-hour window, according to researchers at The University of Texas Medical School at Houston.The results of the study, "Thrombolytic Therapy for Patients Who Wake Up With Stroke," are published in the March issue of Stroke, a journal of the American Heart Association."The results of our study serve as the only published material of patients...

Women are 30 percent less likely than men to get stroke care that limits brain damage, U.S. researchers have found. Specifically, women are less likely to be treated with tissue plasminogen activator, known as tPA, a potent blood thinner used to dissolve the clots which cause most strokes. The finding, the result of analyzing 18 studies involving a total of 2.3 million patients, was presented by Michigan State University, East Lansing, researcher Archit Bhatt at the International Stroke...

Patients who get an experimental clot-busting treatment for a particularly lethal form of stroke improve their chances of survival, U.S. researchers said. Study leader Dr. Daniel Hanley of the Johns Hopkins School of Medicine and colleagues reported early findings among 52 intracranial hemorrhage patients treated with the drug tissue plasminogen activator, given by catheter directly into patients' brains to bathe and destroy blood clots. The researchers worked with patients at 38 study sites...

Young adults with stroke symptoms are sometimes misdiagnosed in emergency rooms "” making them miss effective early treatment "” according to research presented today at the American Stroke Association's International Stroke Conference 2009.In the Misdiagnosis of Acute Stroke in the Young During Initial Presentation in the Emergency Room study, researchers reviewed data on 57 patients, ages 16 to 50 years old, enrolled since 2001 in the Young Stroke Registry at the Comprehensive Stroke...